Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genotropin in very young children born small for gestational age
NCT00627523Phase 3Completed
- Sponsor
- Pfizer
- Start
- Feb 2008
- Primary completion
- Dec 2013
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 9
01
Overview
Phase 3, randomised, open-label trial of genotropin miniquick in Small for gestational age (SGA) (2 arms), sponsored by Pfizer. Primary endpoint: Change From Baseline in Height Standard Deviation Score at 24 months. Started Feb 2008; status: completed.
02
Drugs
genotropin miniquick
03
Conditions
Small for gestational age (SGA)
Beyond the preview
Go deeper on NCT00627523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00627523.